Further opportunities for PCN and Community Pharmacy vaccination sites to partner with community venues to deliver temporary vaccination clinics

Document first published:
Page updated:
Topic:
,
Publication type:

This letter precedes recent JCVI guidance advising that certain COVID-19 vaccines are preferable for specific patient cohorts, which is why it states that the Pfizer/BioNTech vaccine is not suitable for temporary vaccination clinics. The vaccine used should be appropriate for the patient cohorts in question, in line with the latest JCVI advice, and both the Pfizer/BioNTech and AstraZeneca vaccines can be used for temporary vaccination clinics. Further information on roving and mobile models will be available shortly.